Uncovering the dual clinical value of miR-143/145 cluster in bladder cancer epithelium and patients survival outcome

被引：0
|
作者：
Avgeris, M. [1 ]
Tokas, T. [2 ]
Stravodimos, K. [2 ]
Fragoulis, E. G. [1 ]
Scorilas, A. [1 ]
机构：
[1] Univ Athens, Dept Biochem & Mol Biol, Fac Biol, Athens, Greece
[2] Univ Athens, Fac Med, Laiko Gen Hosp, Dept Urol 1, Athens, Greece
来源：
FEBS JOURNAL | 2014年 / 281卷
关键词：
bladder cancer; miR-143; miR-145;
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
MON-071
引用
收藏
页码：275 / 276
页数：2
相关论文
共 34 条
  • [21] High miR-143 is associated with improved survival for ER positive breast cancer patients by targeting KRAS signaling
    Tokumaru, Yoshihisa
    Futamura, Manabu
    Mori, Ryutaro
    Matsuhashi, Nobuhisa
    Yoshida, Kazuhiro
    CANCER SCIENCE, 2022, 113 : 1529 - 1529
  • [22] The Dysregulation of mir-21 and mir-143 as a clinical Marker for Cancer Stem Cells in Tissue Samples of Iraqi Male Patients with Gastrointestinal Sarcoma
    Zedan, Zahraa K.
    Al-Amer, Salah H. A.
    JOURNAL OF PHARMACEUTICAL NEGATIVE RESULTS, 2022, 13 (03) : 20 - 25
  • [23] LncRNA NCK1-AS1 Promotes Cancer Cell Proliferation and Increase Cell Stemness in Urinary Bladder Cancer Patients by Downregulating miR-143
    Qiao, Zhongjie
    Dai, Hongshuang
    Zhang, Yunzhu
    Li, Qiang
    Zhao, Meng
    Yue, Tongyun
    CANCER MANAGEMENT AND RESEARCH, 2020, 12 : 1661 - 1668
  • [24] The value of clinical prognostic factors for survival in patients with invasive urinary bladder cancer
    Asadauskiene, Jolita
    Aleknavicius, Eduardas
    Zelviene, Terese Pipiriene
    Jankevicius, Feliksas
    MEDICINA-LITHUANIA, 2010, 46 (05): : 305 - 314
  • [25] The clinical and prognostic value of miR-9 gene expression in Tunisian patients with bladder cancer
    Boubaker, Nouha Setti
    Cicchillitti, Lucia
    Said, Rahma
    Gurtner, Aymone
    Ayed, Haroun
    Blel, Ahlem
    Karray, Omar
    Essid, Mohamed Ali
    Gharbi, Maroua
    Bouzouita, Abderrazek
    Rommeni, Soumaya Rammeh
    Chebil, Mohamed
    Piaggio, Giulia
    Ouerhani, Slah
    MOLECULAR BIOLOGY REPORTS, 2019, 46 (05) : 4743 - 4750
  • [26] The clinical and prognostic value of miR-9 gene expression in Tunisian patients with bladder cancer
    Nouha Setti Boubaker
    Lucia Cicchillitti
    Rahma Said
    Aymone Gurtner
    Haroun Ayed
    Ahlem Blel
    Omar Karray
    Mohamed Ali Essid
    Maroua Gharbi
    Abderrazek Bouzouita
    Soumaya Rammeh Rommeni
    Mohamed Chebil
    Giulia Piaggio
    Slah Ouerhani
    Molecular Biology Reports, 2019, 46 : 4743 - 4750
  • [27] Uncovering the expression patterns and the clinical significance of miR-182, miR-205, miR-27a and miR-369 in patients with urinary bladder cancer
    Nouha Setti Boubaker
    Aymone Gurtner
    Nesrine Trabelsi
    Isabella Manni
    Haroun Ayed
    Ahmed Saadi
    Zeineb Naimi
    Meriem Ksontini
    Mouna Ayadi
    Ahlem Blel
    Soumaya Rammeh
    Mohamed Chebil
    Giulia Piaggio
    Slah Ouerhani
    Molecular Biology Reports, 2020, 47 : 8819 - 8830
  • [28] Uncovering the expression patterns and the clinical significance of miR-182, miR-205, miR-27a and miR-369 in patients with urinary bladder cancer
    Setti Boubaker, Nouha
    Gurtner, Aymone
    Trabelsi, Nesrine
    Manni, Isabella
    Ayed, Haroun
    Saadi, Ahmed
    Naimi, Zeineb
    Ksontini, Meriem
    Ayadi, Mouna
    Blel, Ahlem
    Rammeh, Soumaya
    Chebil, Mohamed
    Piaggio, Giulia
    Ouerhani, Slah
    MOLECULAR BIOLOGY REPORTS, 2020, 47 (11) : 8819 - 8830
  • [29] MiR-143 Suppresses Breast Cancer Proliferation Through Targeting KRAS and Associates Favorable Tumor Immune Microenvironment with Improved Survival for ER-positive Breast Cancer Patients
    Tokumaru, Yoshihisa
    Oshi, Masanori
    Katsuta, Eriko
    Matsuhashi, Nobuhisa
    Futamura, Manabu
    Yoshidak, Kazuhiro
    Takabe, Kazuaki
    ANNALS OF SURGICAL ONCOLOGY, 2020, 27 (SUPPL 2) : S565 - S566
  • [30] VALUE OF CLINICAL AND MOLECULAR PROGNOSTIC FACTORS FOR SURVIVAL IN PATIENTS WITH INVASIVE BLADDER CANCER TREATED WITH CHEMORADIATION
    Aleknavicius, E.
    Asadauskiene, J.
    Valuckas, K. P.
    Zelviene, T. Pipiriene
    RADIOTHERAPY AND ONCOLOGY, 2010, 96 : S363 - S364
1234